Literature DB >> 1672319

Penicillin-resistant pneumococci in a Merseyside hospital.

E J Ridgway1, K D Allen, A Galloway, A Rigby, M O'Donoghue.   

Abstract

Strains of Streptococcus pneumoniae (N = 915) from clinical specimens were examined for penicillin resistance over a 2-year period. The prevalence of resistance [minimum inhibitory concentration (MIC) greater than 0.1 mg l-1] increased from 1.4 to 2.5% per year during this time. In addition, 83% of penicillin-resistant pneumococci (PRP) showed resistance to chloramphenicol. Most PRP were isolated from uninfected children colonized with the organism, but two out of the three adult cases were clinically infected, one by cross-infection between in-patients. In only two cases was there an association with foreign travel. Three children showed prolonged carriage providing a potential reservoir of infection for other members of the community. The percentage of strains showing high level resistance (MIC greater than 1 mg l-1) increased from 0.7% to 1.9% of all isolates during the 2-year study period. This high prevalence of high level resistance has not been reported previously in the UK and if the trend continues, it will have serious implications for the management of invasive pneumococcal infection, particularly meningitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672319     DOI: 10.1016/0195-6701(91)90073-h

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  2 in total

1.  Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

Authors:  A P Johnson; D C Speller; R C George; M Warner; G Domingue; A Efstratiou
Journal:  BMJ       Date:  1996-06-08

2.  Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan.

Authors:  R Yoshida; M Kaku; S Kohno; K Ishida; R Mizukane; H Takemura; H Tanaka; T Usui; K Tomono; H Koga
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.